EUCTR2005-005850-30-AT进行中（未招募）不适用
ow molecular weight heparin (Fragmin) in pregnant women with a history of uteroplacental insufficiency and thrombophilia, a randomized trial - FRUIT
Medical University Vienna0 个研究点目标入组 262 人开始时间: 2006年1月23日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 262
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Women wit a history of pre-eclampsia and babies small for gestational age before 34 weeks of gestation
- •Thrombophilia
- •Age >18 years
- •Informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •AT-deficiency, diabetes mellitus, known malignancy, gastroduodenal-ulcer, severe renal or hepatic insufficiency, thromboembolism in histoty, hemorrhagic diathesis, ITP
研究者
相似试验
已完成
不适用
ow molecular weight heparin (FRagmin®) in pregnant women with a history of Uteroplacental Insufficiency and Thrombophilia: a randomised trialPre-eclampsiaPre-eclampsia, Small for Gestational Age (SGA)Pregnancy and ChildbirthISRCTN87325378VU University Medical Center (The Netherlands)154
进行中（未招募）
1 期
ow molecular weight heparin in advanced non small cell lung cancer (NSCLC): a randomized open label phase III study evaluating the effect of enoxaparin (Clexane) on survival and symptom control in patients with stage IIIb and IV NSCLC undergoing a cisplatin based first line chemotherapy: the syringes trial - SYRINGESEUCTR2007-007696-16-BETOGA Thoracic Oncology Group Antwerp
已完成
3 期
A study to know the effect of low molecular weight heparin in treatment of acute pancreatitis.CTRI/2021/04/032665SMS Medical Jaipur140
进行中（未招募）
1 期
Heparin in the treatment of fetal growth restrictioEUCTR2020-000315-76-PTCentro Hospitalar Universitário de Lisboa Central, EPE120
进行中（未招募）
1 期
ow-molecular-weight heparin in constituted vascular intrauterine growth restriction.Intrauterine growth restriction (IUGR)MedDRA version: 20.0Level: LLTClassification code 10022819Term: Intrauterine growth retardationSystem Organ Class: 100000004868MedDRA version: 20.0Level: LLTClassification code 10048489Term: Intrauterine growth retardSystem Organ Class: 100000004868MedDRA version: 20.0Level: LLTClassification code 10048488Term: Growth intrauterine retardSystem Organ Class: 100000004868EUCTR2016-000424-25-FRCHU Saint-Etienne162